New bladder cancer cocktail could spare patients from surgery
NCT ID NCT06829823
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This study tests two drug combinations (N-803 with BCG or gemcitabine) given directly into the bladder for people with intermediate-risk non-muscle invasive bladder cancer. The goal is to see if these treatments can eliminate tumors without needing surgery. About 20 adults with low-grade papillary tumors will participate, and the main measure is whether the cancer disappears by 3 or 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.